Movement Alert｜GENSCRIPT BIO Rises 3.02% in Regular Trading, FMR LLC Raises Stake to 5.26%
Market Focus
Yesterday
On October 6, GENSCRIPT BIO rose 3.02% in Regular Trading, trading at HK$47.0/share with turnover of HK$35.09 million.
Financial data shows FMR LLC increased its holdings by acquiring 6.846 million shares at approximately HK$40.25 per share on September 24. This HK$276 million investment lifted its ownership stake from 4.96% to 5.26%, signaling institutional confidence in the company's strategic positioning within the AI-empowered biotech sector.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.